BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 18261353)

  • 1. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
    Li WY; Lai BT; Zhan XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polymorphisms of the CYP1A1 and GSTM1 genes and their combined effects on individual susceptibility to lung cancer in a Chinese population].
    Xue K; Xu L; Chen S; Ma G; Wu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):125-7. PubMed ID: 11295132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility.
    Chen HC; Hu WX; Liu QX; Li WK; Chen FZ; Rao ZZ; Liu XF; Luo YP; Cao YF
    Eur J Cancer Prev; 2008 Jun; 17(3):251-8. PubMed ID: 18414197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the relationship between polymorphisms of Cyp1A1, GSTM1, GSTT1 genes and the susceptibility to acute leukemia in the general population of Hunan province].
    Liu QX; Chen HC; Liu XF; Cao YF; Zhang J; Liu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Dec; 26(12):975-9. PubMed ID: 16676594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women].
    Zhu XX; Hu CP; Gu QH
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Nov; 33(11):817-22. PubMed ID: 21211368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1].
    Li L; Lin P; Deng YF; Zhu ZL; Lu HH
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):2-7. PubMed ID: 15127559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
    Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
    Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people.
    Acevedo C; Opazo JL; Huidobro C; Cabezas J; Iturrieta J; Quiñones Sepúlveda L
    Prostate; 2003 Oct; 57(2):111-7. PubMed ID: 12949934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CYP2D6 and GSTM1 genetic polymorphism and lung cancer susceptibility].
    Gao J; Ren C; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):185-6. PubMed ID: 10921002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.